Related Experiment Video
Updated: May 17, 2025
07:28
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
40.5K
Validation of an AI-Powered Smart Dry Powder Inhaler (RS01X) for Asthma and COPD in a Clinical Setting
Dumiana Chamaon1, Esther Sportel2, Emma C M Elferink1,3
1Department of Pulmonary Medicine, Medisch Spectrum Twente, Enschede, the Netherlands.
Summary
The RS01X smart inhaler accurately measures inhalation technique and adherence in COPD and asthma patients. This validation confirms its potential to improve patient outcomes with inhalation medications.
Area of Science:
- Respiratory Medicine
- Medical Device Technology
Background:
- Inhalation medication is crucial for COPD and asthma management.
- Suboptimal treatment efficacy stems from poor adherence and incorrect inhalation technique.
- Smart inhalers offer a potential solution for monitoring and improving therapy.
Purpose of the Study:
- To validate the RS01X smart dry powder inhaler (DPI) against an external inhalation profile recorder (IPR).
- To assess the smart DPI's accuracy in measuring inhalation parameters.
Main Methods:
- A monocenter cross-sectional study involving 97 participants (COPD, asthma, healthy).
- Participants performed inhalations using the smart DPI under varying conditions (duration, volume, PIF, inhaler angle).
- Paired sample t-tests and intraclass correlation coefficients (ICC) were used for validation.
Main Results:
- The smart DPI demonstrated high correlation with the IPR for all inhalation parameters (ICC > 0.95, p < 0.001).
- No significant differences were observed between healthy subjects and patients with COPD or asthma.
- Negligible differences in volume and PIF were noted with incorrect inhaler angle.
Conclusions:
- The RS01X smart DPI is a valid instrument for measuring inhalation parameters.
- It has the potential to enhance therapy adherence and inhalation technique in patients with asthma and COPD.
Related Concept Videos
01:23Inhaled Medications
205
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
205
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
148
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
148
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
167
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
167